1Lan AN, Tang T, Halapy H, et al. Initiating insulin in patients with type 2 diabetes[ J]. CMAJ, 2012, 184:767-776.
2Nicolucci A, Maione A, Franciosi M, et al. Quality of life and treatment satisfaction in adults with Type 1 diabetes : a comparisonbetween continuous subcutaneous insulin infusion and multiple daily injections[ J]. Diabet Med, 2008,25:213-220.
3Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus [ J ].N Engl J Med, 2012,366:1616-1624.
4Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association ( ADA ) and the European Association for the Study of Diabetes (EASD) [ J ]. Diabetes Care,2012,35 : 1364-1379.
5Maria Rotella C, Pala L, Mannucci E. Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future [ J ]. Int J Endocrinol Metab ,2013,11 : 137-144.
6Monami M, Colombi C, Balzi D, et al. Metformin and cancer occurrence in insulin-treated type 2 diabetic patients[ J]. Diabetes Care,2011,34 : 129-131.
7Monami M, Dicembrini I, Martelli D, et al. Safety of dipeptidyl peptidase-4 inhibitors : a meta-analysis of randomized clinical trials [J]. Curr Med Res Opin, 2011,27 Suppl 3 :S57-64.
8Fonseca V, Gill J, Zhou R, et al. An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia [ J ]. Diabetes Obes Metab,2011,13 : 814 -822.
9Mannucci E, Monami M, Di Bari M, et al. Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials[ J]. Int J Cardiol,2010,143:135-140.
1Loder MK,McDonald A,Tarasov AI,et al.TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells[J]. Diabetes,2009,58(4):894-905.
2Gross TM,Kayne D,King A,et al.Abolus calculator is an effectivemeans of controlling postprandial glycemia in patients Oil insulin pump'therapy[J].Diabetes Technol Ther,2010,13(4):365-369.
